Market Exclusive

Chembio Diagnostics Inc (NASDAQ:CEMI) had its Buy rating reiterated by Canaccord Genuity with a $9.00 price target

Analyst Ratings For Chembio Diagnostics Inc (NASDAQ:CEMI)

Today, Canaccord Genuity reiterated its Buy rating on Chembio Diagnostics Inc (NASDAQ:CEMI) with a price target of $9.00.

There are 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Chembio Diagnostics Inc (NASDAQ:CEMI) is Buy with a consensus target price of $11.50 per share, a potential 91.67% upside.

Some recent analyst ratings include

Recent Trading Activity for Chembio Diagnostics Inc (NASDAQ:CEMI)
Shares of Chembio Diagnostics Inc closed the previous trading session at 6,00 −0,69 10,31 % with shares trading hands.

Exit mobile version